Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units

Vaccine

Volumn 33, Issue 39, 2015, Pages 5095-5102

  Thrall, Samuel ^a   Doll, Margaret K ^a,b   Nhan, Charles ^a   Gonzales, Milagros ^a   Perreault, Thérèse ^a   Lamer, Philippe ^a   Quach, Caroline ^a,b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Preterm infant; Rotavirus; Vaccination

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE;

APNEA; ARTICLE; ATTRIBUTABLE RISK; BRADYCARDIA; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; GASTROENTERITIS; HOSPITAL; HOSPITAL INFECTION; HOSPITALIZATION; HOSPITALIZED INFANT; HUMAN; INFANT; INFANT DISEASE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; ROTAVIRUS INFECTION; TOTAL PARENTERAL NUTRITION; VACCINATION; VIRUS TRANSMISSION; VOMITING; CROSS INFECTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; IMMUNOLOGY; NEWBORN; ROTAVIRUS INFECTIONS; TREATMENT OUTCOME; URBAN POPULATION;

CROSS INFECTION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; GASTROENTERITIS; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; RETROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TREATMENT OUTCOME; URBAN POPULATION; VACCINES, ATTENUATED;

EID: 84941744871     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.015     Document Type: Article

References (46)

1. Buigues R.P., Duval B., Rochette L., Boulianne N., Douville-Fradet M., Dery P., et al. Hospitalizations for diarrhea in Quebec children from 1985 to 1998: estimates of rotavirus-associated diarrhea. Can J Infect Dis 2002, 13:239-244.
2. Ford-Jones E.L., Wang E., Petric M., Corey P., Moineddin R., Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med 2000, 154:578-585.
3. Ford-Jones E.L., Wang E., Petric M., Corey P., Moineddin R., Fearon M. Rotavirus-associated diarrhea in outpatient settings and child care centers. Arch Pediatr Adolesc Med 2000, 154:586-593. The Greater Toronto Area/Peel Region PRESI Study Group, Pediatric Rotavirus Epidemiology Study for Immunization.
4. Rivest P., Proulx M., Lonergan G., Lebel M.H., Bedard L. Hospitalisations for gastroenteritis: the role of rotavirus. Vaccine 2004, 22:2013-2017.
5. Senecal M., Brisson M., Lebel M.H., Yaremko J., Wong R., Gallant L.A., et al. Measuring the impact of rotavirus acute gastroenteritis episodes (MIRAGE): a prospective community-based study. J Can Maladies Infect Microbiol Med/AMMI Canada 2008, 19:397-404.
6. Waters V., Ford-Jones E.L., Petric M., Fearon M., Corey P., Moineddein R. Etiology of community-acquired pediatric viral diarrhea: a prospective longitudinal study in hospitals, emergency departments, pediatric practices and child care centers during the winter rotavirus outbreak, 1997 to 1998. The Pediatric Rotavirus Epidemiology Study for Immunization Study Group. Pediatr Infect Dis J 2000, 19:843-848.
7. Committee on Infectious Diseases, American Academy of Pediatrics Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 2009, 123:1412-1420.
8. Cortese M.M., Parashar U.D., Centers for Disease Control and Prevention Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58:1-25. (Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control).
9. National Advisory Committee on Immunization (NACI) Updated statement on the use of rotavirus vaccines. Can Commun Dis Rep 2010, 36:ACS-4.
10. Comité sur l'immunisation du Québec Protocole D'Immunisation du Québec 2013, Édition Mai 2013.
11. Braeckman T., Van Herck K., Meyer N., Pircon J.Y., Soriano-Gabarro M., Heylen E., et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ 2012, 345:e4752.
12. Cortese M.M., Immergluck L.C., Held M., Jain S., Chan T., Grizas A.P., et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013, 132:e25-e33.
13. Martinon-Torres F., Bouzon Alejandro M., Redondo Collazo L., Sanchez Lastres J.M., Pertega Diaz S., Seoane Pillado M.T., et al. Effectiveness of rotavirus vaccination in Spain. Hum Vaccines 2011, 7:757-761.
14. Payne D.C., Boom J.A., Staat M.A., Edwards K.M., Szilagyi P.G., Klein E.J., et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis 2013, 57:13-20. (an official publication of the Infectious Diseases Society of America).
15. Chang W.C., Yen C., Wu F.T., Huang Y.C., Lin J.S., Huang F.C., et al. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants. Pediatr Infect Disease J 2014, 33:e81-e86.
16. Marlow R., Ferreira M., Cordeiro E., Trotter C., Januario L., Finn A., et al. Case control study of rotavirus vaccine effectiveness in Portugal during six years of private market use. Pediatr Infect Dis J 2015, 34:509-512.
17. Castilla J., Beristain X., Martinez-Artola V., Navascues A., Garcia Cenoz M., Alvarez N., et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine 2012, 30:539-543.
18. Health Section of the Secretariat of the League of Nations/Section d'hygiene du Secretariat de la Societe des Nations Rotavirus vaccine and intussusception: report from an expert consultation. Releve epidemiologique hebdomadaire. Wkly Epidemiol Rec 2011, 86:317-321.
19. Dennehy P.H., Cortese M.M., Begue R.E., Jaeger J.L., Roberts N.E., Zhang R., et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J 2006, 25:1123-1131.
20. Newman R.D., Grupp-Phelan J., Shay D.K., Davis R.L. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 1999, 103:E3.
21. Public Health Agency of Canada Part 3 Vaccination of specific populations: immunization of infants born prematurely. Canadian Immunization Guide 2013.
22. Public Health Agency of Canada Part 4. Active vaccines: rotavirus vaccine. Canadian Immunization Guide 2012.
23. Australian Government Department of Health Part 4. Vaccine-preventable diseases: rotavirus. The Australian immunisation handbook 2013, 10th ed.
24. Public Health England Rotavirus: the green book. Immunisation against infectious disease 2013, (Chapter 27b). D. Salisbury, M. Ramsay (Eds.).
25. Monk H.M., Motsney A.J., Wade K.C. Safety of rotavirus vaccine in the NICU. Pediatrics 2014, 133:e1555-e1560.
26. Jaques S.C., Ogley L., Duffy D., Kennea N. Rotavirus immunisation in NICU: a 1-year experience in a UK tertiary neonatal surgical unit postvaccine introduction. Arch Dis Child Fetal Neonatal Ed 2015, 100:F186-F187.
27. Stumpf K.A., Thompson T., Sanchez P.J. Rotavirus vaccination of very low birth weight infants at discharge from the NICU. Pediatrics 2013, 132:e662-e665.
28. Cortese M.M., Parashar U.D., Centers for Disease Control and Prevention Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58:1-25. (Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control).
29. Anderson E.J. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008, 8:642-649.
30. Payne D.C., Edwards K.M., Bowen M.D., Keckley E., Peters J., Esona M.D., et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics 2010, 125:e438-e441.
31. Rivera L., Pena L.M., Stainier I., Gillard P., Cheuvart B., Smolenov I., et al. Horizontal transmission of a human rotavirus vaccine strain-a randomized, placebo-controlled study in twins. Vaccine 2011, 29:9508-9513.
32. Smith C.K., McNeal M.M., Meyer N.R., Haase S., Dekker C.L. Rotavirus shedding in premature infants following first immunization. Vaccine 2011, 29:8141-8146.
33. Montréal Children's Hospital, McGill University Health Centre. The MCH neonatology program: open, responsive, collaborative. Access date: November 12, 2014. http://www.thechildren.com/news-and-events/latest-news/mch-neonatology-program-open-responsive-collaborative.
34. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
35. Singer J.D., Willett J.B. Applied longitudinal data analysis: modeling change and event occurrence 2003, Oxford University Press, New York, NY.
36. SAS Institute Usage note 37344: estimating rate differences (with confidence interval) using a Poisson model October, 2009, SAS Institute, http://support.sas.com/kb/37/344.html Access date: January 9, 2015.
37. Rothman K.J., Young-Xu Y., Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis 2006, 193:898. (author reply-9).
38. Simonsen L., Viboud C., Elixhauser A., Taylor R.J., Kapikian A.Z. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 2005, 192(Suppl 1):S36-S43.
39. Patel M.M., Clark A.D., Glass R.I., Greenberg H., Tate J., Santosham M., et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009, 27:2916-2922.
40. Merck & Co, Inc Rotateq (rotavirus vaccine, live, oral, pentavalent) 2010, Merck & Co, Inc, Whitehouse Station, NJ, [package insert].
41. Botham S.J., Isaacs D. Incidence of apnoea and bradycardia in preterm infants following triple antigen immunization. J Paediatr Child Health 1994, 30:533-535.
42. Carbone T., McEntire B., Kissin D., Kelly D., Steinschneider A., Violaris K., et al. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. Pediatrics 2008, 121:e1085-e1090.
43. Pfister R.E., Aeschbach V., Niksic-Stuber V., Martin B.C., Siegrist C.A. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr 2004, 145:58-66.
44. Sanchez P.J., Laptook A.R., Fisher L., Sumner J., Risser R.C., Perlman J.M. Apnea after immunization of preterm infants. J Pediatr 1997, 130:746-751.
45. Schulzke S., Heininger U., Lucking-Famira M., Fahnenstich H. Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. Eur J Pediatr 2005, 164:432-435.
46. Gagneur A, Pinquier D, Quach C, Immunization of Preterm Infants, Hum Vaccin Immunother: article in press.